Maxigen Biotech Inc.

TWSE:1783 株式レポート

時価総額：NT$4.0b

Maxigen Biotech バランスシートの健全性

財務の健全性 基準チェック /66

Maxigen Biotechの総株主資本はNT$1.3B 、総負債はNT$0.0で、負債比率は0%となります。総資産と総負債はそれぞれNT$1.5BとNT$198.4Mです。 Maxigen Biotechの EBIT はNT$149.1Mで、利息カバレッジ比率-6.4です。現金および短期投資はNT$545.3Mです。

主要情報

0%

負債資本比率

NT$0

負債

インタレスト・カバレッジ・レシオ-6.4x
現金NT$545.26m
エクイティNT$1.33b
負債合計NT$198.36m
総資産NT$1.53b

財務の健全性に関する最新情報

更新なし

Recent updates

Maxigen Biotech's (TWSE:1783) Shareholders Have More To Worry About Than Only Soft Earnings

Nov 20
Maxigen Biotech's (TWSE:1783) Shareholders Have More To Worry About Than Only Soft Earnings

Maxigen Biotech's (TWSE:1783) Earnings Are Of Questionable Quality

Mar 28
Maxigen Biotech's (TWSE:1783) Earnings Are Of Questionable Quality

Maxigen Biotech Inc. (TPE:1783) Is Yielding 2.3% - But Is It A Buy?

Apr 22
Maxigen Biotech Inc. (TPE:1783) Is Yielding 2.3% - But Is It A Buy?

We Think You Should Be Aware Of Some Concerning Factors In Maxigen Biotech's (TPE:1783) Earnings

Apr 01
We Think You Should Be Aware Of Some Concerning Factors In Maxigen Biotech's (TPE:1783) Earnings

Maxigen Biotech Inc.'s (TPE:1783) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Mar 16
Maxigen Biotech Inc.'s (TPE:1783) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

The Maxigen Biotech (TPE:1783) Share Price Has Gained 22% And Shareholders Are Hoping For More

Feb 23
The Maxigen Biotech (TPE:1783) Share Price Has Gained 22% And Shareholders Are Hoping For More

Can Maxigen Biotech (TPE:1783) Continue To Grow Its Returns On Capital?

Feb 02
Can Maxigen Biotech (TPE:1783) Continue To Grow Its Returns On Capital?

Tread With Caution Around Maxigen Biotech Inc.'s (TPE:1783) 3.4% Dividend Yield

Jan 10
Tread With Caution Around Maxigen Biotech Inc.'s (TPE:1783) 3.4% Dividend Yield

Declining Stock and Decent Financials: Is The Market Wrong About Maxigen Biotech Inc. (TPE:1783)?

Dec 14
Declining Stock and Decent Financials: Is The Market Wrong About Maxigen Biotech Inc. (TPE:1783)?

If You Had Bought Maxigen Biotech's (TPE:1783) Shares Five Years Ago You Would Be Down 13%

Nov 22
If You Had Bought Maxigen Biotech's (TPE:1783) Shares Five Years Ago You Would Be Down 13%

財務状況分析

短期負債: 1783の 短期資産 ( NT$744.2M ) が 短期負債 ( NT$196.6M ) を超えています。

長期負債: 1783の短期資産 ( NT$744.2M ) が 長期負債 ( NT$1.7M ) を上回っています。

デット・ツー・エクイティの歴史と分析

負債レベル: 1783は負債がありません。

負債の削減: 1783負債比率が25.4%であった 5 年前と比べて負債がありません。

債務返済能力: 1783には負債がないため、営業キャッシュフロー でカバーする必要はありません。

インタレストカバレッジ: 1783には負債がないため、利息支払い の負担は問題になりません。

貸借対照表

健全な企業の発掘

7D

1Y

7D

1Y

7D

1Y